Can a weekly injection protect the joints of hemophilia patients?
NCT ID NCT05643560
Summary
This study is observing adults with hemophilia A who are taking the medication Jivi to see if long-term use improves their joint health. Researchers will use ultrasound scans to check the condition of participants' joints before starting Jivi and again after two years of treatment. The goal is to gather real-world evidence on whether this preventative treatment helps protect joints from damage caused by bleeding episodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Italy
Conditions
Explore the condition pages connected to this study.